Antineoplastic and Apoptotic Potential of Traditional Medicines Thymoquinone and Diosgenin in Squamous Cell Carcinoma
Year: 2012
Type: article
Abstract: Thymoquinone (TQ) and diosgenin (DG), the active ingredients obtained from black cumin (Nigella sativa) and fenugreek (Trigonella foenum graecum), respectively, exert potent bioactivity, including anticancer effects. This study investigated the antineoplastic activity of these agents against squamous cell carcinoma in vitro and sarcoma 180-induced tumors in vivo. TQ and DG inhibited cell proliferation and induced cytotoxicity in A431 and Hep2 cells. These agents induced apoptosis by increasing the sub-G(1) population, LIVE/DEAD cytotoxicity, chromatin condensation, DNA laddering and TUNEL-positive cells significantly (P<0.05). Increased Bax/Bcl-2 ratio, activation of caspases and cleavage of poly ADP ribose polymerase were observed in treated cells. These drugs inhibited Akt and JNK phosphorylations, thus inhibiting cell proliferation while inducing apoptosis. In combination, TQ and DG had synergistic effects, resulting in cell viability as low as 10%. In a mouse xenograft model, a combination of TQ and DG significantly (P<0.05) reduced tumor volume, mass and increased apoptosis. TQ and DG, alone and in combination, inhibit cell proliferation and induce apoptosis in squamous cell carcinoma. The combination of TQ and DG is a potential antineoplastic therapy in this common skin cancer.
Source: PLoS ONE
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Keywords: thymoquinone, diosgenin, squamous cell carcinoma, apoptosis, anticancer activity, Nigella sativa, fenugreek, traditional medicine, A431 cells, HEp-2 cells, sarcoma 180, Bax/Bcl-2 ratio, caspase activation, PARP cleavage, Akt phosphorylation, JNK phosphorylation, synergistic drug combination, skin cancer, xenograft tumor model
Open Access status: gold
Estimated APC paid: $2,382
OpenAlex ID: W2041887393
